ID   KSCBi002-B-2
AC   CVCL_C9IN
SY   TNFRSF11B-KO hiPSCs; CNUi003-A-2
DR   BioSamples; SAMEA114594495
DR   hPSCreg; KSCBi002-B-2
DR   Wikidata; Q123032854
RX   PubMed=37481965;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11909; TNFRSF11B.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131861; Juvenile Paget disease
DI   ORDO; Orphanet_2801; Juvenile Paget disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT64 ! KSCBi002-B
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
RX   PubMed=37481965; DOI=10.1016/j.scr.2023.103167;
RA   Jeong, Jujin
RA   Lee, Dahye
RA   Park, Byeong-Cheol
RA   Lee, Tae-Hoon
RA   Park, Sang-Wook
RT   "Establishment of a TNFRSF11B knock-out human induced pluripotent stem
RT   cell line (KSCBi002-B-2) via CRISPR/Cas9 system.";
RL   Stem Cell Res. 71:103167-103167(2023).
//